New lupus drug shows early promise in small trial
NCT ID NCT05638802
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested an experimental drug called DS-7011a in 26 adults with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The study aimed to check the drug's safety and how the body processes it, not yet to prove it works. Participants received either the drug or a placebo intravenously every 4 weeks for three doses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DS-7011a (an experimental drug given intravenously)
- What this could lead to
- If successful, this could point toward a new treatment option for lupus that is safer and more effective than current therapies.
- What could go wrong
- This is a very early, small study (26 people) focused on safety and dosing, not on proving the drug works. Many promising early-stage drugs fail in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arkansas Research Trials
North Little Rock, Arkansas, 72117, United States
-
Hospital of the University of Occupational and Environmental Health
Kitakyushu-shi, 807-8556, Japan
-
Japan Community Health Care Organization Chukyo Hospital
Nagoya, 457-8510, Japan
-
Jcho Tokyo Yamate Medical Center
Shinjuku-ku, 169-0073, Japan
-
Joint & Muscle Research Institute
Charlotte, North Carolina, 28204, United States
-
MediSearch Clinical Trials
Saint Joseph, Missouri, 64506, United States
-
Metroplex Clinical Research Center, LLC
Dallas, Texas, 75231, United States
-
Oakland Hills Dermatology
Auburn Hills, Michigan, 48326, United States
-
Office of Tory P. Sullivan, M.D. - North Miami Beach
North Miami Beach, Florida, 33162, United States
-
Phi University Clinic of Rheumatology Skopje
Skopje, 1000, North Macedonia
-
Pinnacle Research Group LLC
Anniston, Alabama, 36207, United States
-
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas, 76034, United States
-
Renji Hospital Shanghai Jiaotong University School of Medicine - West Branch
Shanghai, 200001, China
-
Revival Research Institute, LLC
Troy, Michigan, 48084, United States
-
The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
Tohoku University Hospital
Sendai, 980-8574, Japan
-
Trinity Health Center Medical Arts
Minot, North Dakota, 58701, United States
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, 430022, China
-
West Broward Rheumatology Associates
Tamarac, Florida, 33321, United States
-
Yokohama City University Medical Center
Yokohama, 232-0024, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a smartphone app bridge the lupus care gap for women of color?